--- title: "BetterLife Pharma (BETR) news: offering and convertible notes" url: "https://aibio.space/companies/betterlife-pharma/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "BETR offering and convertible notes news: BetterLife closes CAD $2,000,000 convertible debenture financing. BetterLife Pharma Inc. (CSE: BETR), Canada." --- BETR BetterLife Pharma Inc. CSE · Canada # BetterLife Pharma (BETR) news BETR offering and convertible notes news Debt Financing · 2026-06-22 ## [BetterLife closes CAD $2,000,000 convertible debenture financing](https://aibio.space/news/betterlife-closes-cad-2-000-000-convertible-debenture-financing/) BetterLife Pharma closed a CAD $2,000,000 convertible debenture on June 22, 2026, and a director and insider subscribed for the full amount. The conversion price compares with $0.07 per unit in an April 2026 private placement. ## Latest BetterLife Pharma news We have not published a story on BetterLife Pharma yet. When there is news, it will appear here. ## BetterLife Pharma at a glance - **Ticker**: BETR - **Listing**: CSE - **Country**: Canada - **Cash, Oct 31, 2018**: $406,901 ### Related companies - [Satellos Bioscience](https://aibio.space/companies/satellos-bioscience/) TSX: MSCL - [Marvel Biosciences](https://aibio.space/companies/marvel-biosciences/) TSXV: MRVL - [Allstar Health Brands](https://aibio.space/companies/allstar-health-brands/) OTC: ALST - [Medexus Pharmaceuticals](https://aibio.space/companies/medexus-pharmaceuticals/) TSX: MDP - [Waverley Pharma](https://aibio.space/companies/waverley-pharma/) TSXV: WAVE - [Knight Therapeutics](https://aibio.space/companies/knight-therapeutics/) TSX: GUD - [Edesa Biotech](https://aibio.space/companies/edesa-biotech/) NASDAQ: EDSA - [HLS Therapeutics](https://aibio.space/companies/hls-therapeutics/) TSX: HLS ### Also on CSE - [Bright Minds Biosciences](https://aibio.space/companies/bright-minds-biosciences/) DRUG - [Entheon Biomedical](https://aibio.space/companies/entheon-biomedical/) ENBI.X - [PreveCeutical Medical](https://aibio.space/companies/preveceutical-medical/) PREV - [LIR Life Sciences](https://aibio.space/companies/lir-life-sciences/) SKNY - [Mindbio Therapeutics](https://aibio.space/companies/mindbio-therapeutics/) MBIO - [Neural Therapeutics](https://aibio.space/companies/neural-therapeutics/) NURL ## What BetterLife Pharma does BetterLife Pharma Inc. is a biopharmaceutical company, incorporated in British Columbia, Canada, that is engaged in the development of patented pharmaceuticals. Its lead program, BETR-001, is a non-hallucinogenic second-generation LSD derivative, 2-bromo-LSD, that the company plans to develop for major depressive disorder, anxiety disorder, neuropathic pain and other neuro-psychiatric and neurological disorders. The company says BETR-001 is at the preclinical stage, with GMP manufacturing of oral capsules being completed. Its subsidiary MedMelior Inc. has two pipeline products: MM-001, a topical formulation of recombinant human IFNa2b for cervical intraepithelial neoplasia, and MM-003, a patent pending inhalation formulation of interferon alpha-2b. The company intends to use contract development and manufacturing organizations on a fee for service basis. Its stated goal is to develop BETR-001 as a patient self-administered medication prescribed by a psychiatrist. | Product or program | What it is | Stage | |---|---|---| | BETR-001 | Non-hallucinogenic 2-bromo-LSD derivative for depression, anxiety and neuropathic pain | preclinical | | MM-001 | Topical IFNa2b cream for HPV-induced cervical intraepithelial neoplasia | clinical stage; Phase 1-2 trials completed | | MM-003 | Patent pending inhalation formulation of interferon alpha-2b | preclinical | Summarised from the company's [20-F filed Jun 1, 2026](https://www.sec.gov/Archives/edgar/data/1464165/000147793226003553/betrf_20f.htm). ## BetterLife Pharma annual financials | Line | FY ended Jan 31, 2018 | FY ended Jan 31, 2017 | |---|---|---| | Research and development | [$70,304](https://www.sec.gov/Archives/edgar/data/1464165/000147793218002135/) | | | Net income (loss) | [-$121,182](https://www.sec.gov/Archives/edgar/data/1464165/000147793218002135/) | [-$6.3 million](https://www.sec.gov/Archives/edgar/data/1464165/000147793218002135/) | | Cash from operations | [-$395,602](https://www.sec.gov/Archives/edgar/data/1464165/000147793218002135/) | [-$359,449](https://www.sec.gov/Archives/edgar/data/1464165/000147793218002135/) | | Cash and equivalents | [$64,511](https://www.sec.gov/Archives/edgar/data/1464165/000147793218006051/) | [$112,421](https://www.sec.gov/Archives/edgar/data/1464165/000147793218006051/) | Latest balance sheet, Oct 31, 2018 (10-Q): cash and equivalents $406,901. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about BetterLife Pharma Has BetterLife Pharma raised money recently? Our latest story on this, dated Jun 22, 2026: "BetterLife closes CAD $2,000,000 convertible debenture financing". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/betterlife-closes-cad-2-000-000-convertible-debenture-financing/). Has BetterLife Pharma sold convertible notes? Our latest story on this, dated Jun 22, 2026: "BetterLife closes CAD $2,000,000 convertible debenture financing". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/betterlife-closes-cad-2-000-000-convertible-debenture-financing/). What is the ticker symbol of BetterLife Pharma? BetterLife Pharma Inc. trades under the ticker BETR on CSE. Where is BetterLife Pharma listed? BetterLife Pharma Inc. is listed on CSE. Our directory also records these other listings: GETTEX:NPAU; LS:A2P7XN; LSX:A2P7XN; NEO:BETR; OTC:BETRF. What is the SEC CIK of BetterLife Pharma? The SEC Central Index Key (CIK) for BetterLife Pharma Inc. is 1464165. Its filings are on SEC EDGAR. How many shares does BetterLife Pharma have outstanding? 145,494,883 shares as of 2025-05-30, per the cover page of its 20-F filed 2025-06-02. Which country or territory is BetterLife Pharma listed under? Our directory records BetterLife Pharma Inc. under Canada. What does BetterLife Pharma do? Our directory classifies BetterLife Pharma Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of BetterLife Pharma? The ISIN recorded for BetterLife Pharma Inc. is CA08772P2026. Does aibio.space cover BetterLife Pharma? aibio.space lists BetterLife Pharma Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is BetterLife Pharma incorporated? SEC records list its state or country of incorporation as A1. What does BetterLife Pharma develop? BetterLife Pharma Inc. is a biopharmaceutical company, incorporated in British Columbia, Canada, that is engaged in the development of patented pharmaceuticals. Its lead program, BETR-001, is a non-hallucinogenic second-generation LSD derivative, 2-bromo-LSD, that the company plans to develop for major depressive disorder, anxiety disorder, neuropathic pain and other neuro-psychiatric and neurological disorders. What is BETR-001 from BetterLife Pharma? BETR-001: Non-hallucinogenic 2-bromo-LSD derivative for depression, anxiety and neuropathic pain Stage: preclinical. What is MM-001 from BetterLife Pharma? MM-001: Topical IFNa2b cream for HPV-induced cervical intraepithelial neoplasia Stage: clinical stage; Phase 1-2 trials completed. Is BetterLife Pharma profitable? BetterLife Pharma Inc. reported a net loss of $121,182 for the fiscal year ended Jan 31, 2018, and used $395,602 of cash in operations, per its annual report to the SEC. ## Investor discussion: BetterLife Pharma Members talk about BetterLife Pharma (BETR). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at BetterLife Pharma, newest first. Each line links the filing it comes from. 1. 2025-05-30 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1464165/000147793225004242/betrf_ex991.htm) 2. 2025-04-07 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1464165/000147793225002493/betrf_ex991.htm) 3. 2024-12-09 Listings Reported a reverse stock split. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1464165/000147793224007925/betrf_ex991.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open CSE:BETR on TradingView](https://www.tradingview.com/symbols/CSE-BETR/). ## SEC filings and registration - **SEC name**: BetterLife Pharma Inc. - **CIK**: 1464165 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: BETRF (OTC) - **State or country of incorporation**: A1 - **Fiscal year ends**: January 31 - **Filer category**: Non-accelerated filer - **Business address**: 1275 WEST 6TH AVENUE, VANCOUVER, British Columbia, Canada, V6H 1A6 - **Phone**: 438-884-8841 - **Shares outstanding**: 145,494,883 as of 2025-05-30 (20-F filed 2025-06-02) - **Former names**: Pivot Pharmaceuticals Inc.; Neurokine Pharmaceuticals Inc. ### Recent filings (8-K and 6-K are the company's own announcements) - [6-K](https://www.sec.gov/Archives/edgar/data/1464165/000147793226005911/betrf_6k.htm) filed 2026-09-30 - [6-K](https://www.sec.gov/Archives/edgar/data/1464165/000147793226005599/betrf_6k.htm) filed 2026-09-15 - [6-K](https://www.sec.gov/Archives/edgar/data/1464165/000147793226005526/betrf_6k.htm) filed 2026-09-11 - [6-K](https://www.sec.gov/Archives/edgar/data/1464165/000147793226005238/betrf_6k.htm) filed 2026-08-24 - [6-K](https://www.sec.gov/Archives/edgar/data/1464165/000147793226004714/betrf_6k.htm) filed 2026-08-05 - [6-K](https://www.sec.gov/Archives/edgar/data/1464165/000147793226004038/betrf_6k.htm) filed 2026-06-26 - [6-K](https://www.sec.gov/Archives/edgar/data/1464165/000147793226004001/betrf_6k.htm) filed 2026-06-25 - [20-F](https://www.sec.gov/Archives/edgar/data/1464165/000147793226003553/betrf_20f.htm) filed 2026-06-01 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001464165), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details BetterLife Pharma Inc. is a public biotech or pharmaceutical company listed on CSE under the ticker BETR, recorded under Canada. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: BetterLife Pharma Inc. - **Ticker**: BETR - **Listing**: CSE - **Country or territory**: Canada - **Business scope**: Pharmaceuticals: Major - **ISIN**: CA08772P2026 - **Other listed symbols**: GETTEX:NPAU; LS:A2P7XN; LSX:A2P7XN; NEO:BETR; OTC:BETRF - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/CSE-BETR/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/betterlife-pharma/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "BetterLife Pharma (BETR) news: offering and convertible notes", 2026-10-31, https://aibio.space/companies/betterlife-pharma/